Las Vegas Sands

Barclays

Barclays Raises Las Vegas Sands Price Target to $65, Maintains Overweight Rating.

金沙集团

Morgan Stanley maintains Las Vegas Sands at Equal-Weight, raises PT to $67.

Las Vegas Sands: Barclays maintains Overweight, raises PT to $65 from $62.

Las Vegas Sands Triggers MACD Death Cross, KDJ Death Cross on 15min Chart.

Las Vegas Sands RSI Oversold, KDJ Golden Cross on 15-Minute Chart.

Catalyst<ul> <li>Bullish signals are obviously dominant (1 bullish vs 0 bearish) in recent technical indicators for LVS.</li> <li>Most analysts rate LVS Buy or Strong Buy, showing broad institutional optimism.</li> <li>The company maintains strong cash reserves relative to market value.</li></ul>Risk<ul> <li>Net outflow trends across all fund size buckets indicate negative fund flows for LVS.</li> <li>Analyst ratings show differences, with one firm maintaining a Neutral rating, citing valuation concerns.</li> <li>Negative factors in fundamental analysis include inventory turnover days and diluted earnings per share growth concerns.</li></ul>

Key Factors

Las Vegas Sands reported Q3 2025 Singapore revenue of $1.44 billion a 56.3% increase driven by completed capital investments. Marina Bay Sands generated adjusted property EBITDA of $743 million a 83% increase making it the world's most profitable casino property. Barclays raised Las Vegas Sands price target to $65 from $62 and maintained an Overweight rating. Morgan Stanley raised Las Vegas Sands price target to $67 and maintained Equal-Weight rating.

Recent Updates

LVS News